Ipsen be­comes the lat­est phar­ma to ex­pand in Ire­land, with a $50M in­vest­ment in its fa­cil­i­ty in Dublin sub­urbs

It is no se­cret that Ire­land has be­come a hot spot for phar­ma man­u­fac­tur­ing projects over the past year, and it seems that Ipsen will be the lat­est play­er to get in on the ac­tion.

On Mon­day Ipsen un­veiled the €52 mil­lion ($49.9 mil­lion) ex­pan­sion it made in­to its ac­tive phar­ma­ceu­ti­cal in­gre­di­ent man­u­fac­tur­ing fa­cil­i­ty in Blan­chard­stown, a small sub­urb of Dublin. The in­vest­ment is aimed at boost­ing med­i­cine and in­gre­di­ent pro­duc­tion in can­cer and rare dis­ease space.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER